Clinical Trials · NCT05040971
Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 207
- Start date
- Sep 2021
- Locations
- 43 sites, 5 countries
- Primary endpoint
- Change in Body Weight (Percentage [%])